• EN

Scientific award



Scientific award

The scientific award, inaugurated in 2011 by the EMCDDA and its Scientific Committee, celebrates scientific writing and distinguishes high-quality research in the field of illicit drugs. Scientific papers judged to enhance understanding of the European drugs problem are acknowledged yearly in an award ceremony.

2015 award

In 2015, the paper award committee received over 50 eligible articles and will select up to five papers of outstanding quality to be awarded a prize, based on the following criteria:

  • scientific originality;
  • scientific quality;
  • clarity and quality of writing; and
  • EU relevance.

This year's ceremony was held on 23 September (Lisbon) in the margins of the First European conference on addictive behaviours and dependencies, which provided a unique networking opportunity for researchers, practitioners and policy experts across countries and disciplines to discuss latest findings on the prevention, treatment and control of addiction.

For more information on the conference visit www.lisbonaddictions.eu

Links to abstracts and full text (where available) of the winning papers are available online.

2015 EMCDDA Scientific paper award

Nomination and eligibility

The award showcases innovative research in the drugs field. Each year, the EMCDDA asks its partners to nominate papers focusing on illicit drugs or new psychoactive substances. The articles will have been published in the previous year in a peer-reviewed scientific journal, with the primary author being of European nationality or based in a European country.

  • Each nominated paper should be classified according to the following research fields:
  • Basic biological, neurobiological and behavioural research (including aetiological and addictive behaviour research);
  • Population based research and clinical epidemiology (including site surveys, ethnographic studies and acute toxicity studies);
  • Demand reduction (including prevention, treatment, harm reduction, reintegration and clinical treatment research);
  • Supply, supply reduction and crime;
  • Drug policy (including laws, economic issues and strategies);
  • Other topics.

The scientific award was inaugurated in 2011 to showcase innovative research in drugs field.

2014 award

2013 award

2012 award

2011 award


About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Monday, 22 February 2016